|
- 2019
The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreatic cancerDOI: 10.1186/s40880-019-0367-7 Keywords: Pancreatic cancer, Metastatic, Chemotherapy, FOLFIRINOX, Dose modification, First-line, Multicenter, Overall response rate, Efficacy, Safety Abstract: Demographic and baseline characteristics of the enrolled patient
|